Fei Zhou

1.2k citations
54 papers · 977 indexed · h-index 19
Topics
NF-κB Signaling Pathways (10 papers)MicroRNA in disease regulation (7 papers)Cancer-related molecular mechanisms research (6 papers)

In The Last Decade

Fei Zhou

47 papers receiving 966 citations

Peers

Fei Zhou
Comparison fields: 5 of 102
  • Molecular Biology 562
  • Cancer Research 274
  • Oncology 158
  • Immunology 134
  • Physiology 94
Replace Antonios N. Gargalionis with:
Antonios N. Gargalionis Greece
Lingling Liu China
Avital Eisenberg‐Lerner Israel
Hamid Galehdari Iran
Bing Xu China
Elisabeth Corcelle–Termeau Denmark
Wen Zheng China
Yohannes A. Mebratu United States
Lili Deng China
Daniel Meley France
Fei Zhou relative to Antonios N. Gargalionis Greece Antonios N. Gargalionis's profile →
Citations per field
00.5×1.5×
Antonios N. Gargalionis · 1×
Citations per year

Countries citing papers authored by Fei Zhou

Since Specialization
Citations

This map shows the geographic impact of Fei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Zhou more than expected).

Fields of papers citing papers by Fei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Zhou. The network helps show where Fei Zhou may publish in the future.

Co-authorship network of co-authors of Fei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Zhou. A scholar is included among the top collaborators of Fei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Zhou. Fei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 7
5 3
6 26
7 5
8 3
9 0
10 17
11 88
12 17
13 28
14 8
15 96
16
Clinical significance of the expressions of PTEN and p-AKT proteins in gastric carcinoma and its relationship to prognosis
1
17 34
18 69
19 31
20
Construction of the plasmid pCMV4-rZPC^ DNA vaccine and analysis of its expression in mouse
1

About Fei Zhou

Fei Zhou is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Molecular Biology, having authored 54 papers that have together received 977 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (10 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (562 citations) and Immunology (134 citations). Fei Zhou has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Jinke Wang, Xinhui Xu, Lei Zhang, Jun Yang, Jiawang Ding, Hui Wu, En‐Min Li, Yang‐Min Xie, Jian‐Jun Xie and Li‐Yan Xu. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026